|
|
|
| Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D. | Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician — work he continues even as he builds Tome Biosciences, where he serves as President & CEO. On Business of Biotech, Dr. Kakkar shares how his work as a physician informs his leadership, biopharma’s bad rap, and a whole lot more. |
|
|
|
|
By BioPhorum | This article outlines strategies for reducing testing volumes required for gene therapies, which, in turn, conserves product for patients while maintaining compliance. |
|
|
|
| Optimize DNA Storage Using Dedicated Fluoropolymer Film | Webinar | Entegris, Inc. | Discover how to integrate appropriate materials and tools for oligonucleotide handling, optimize DNA storage using dedicated fluoropolymer film, perform complex biochemical reactions in bags, and more. |
|
|
|
| Choose The Right Reagent For Your Testing Needs | Article | FUJIFILM Wako Chemicals U.S.A. Corp. | Five factors to consider when meeting the challenge of evaluating numerous available products from various manufacturers and selecting reagents that meet your specific experimental needs. |
|
|
|
|
|
|
|
|
|
A conversation with Diane Hustead, Merck & Co. | The ISPE's Drug Shortages Prevention Model revamps its predecessor, the more prescriptive Drug Shortages Prevention Plan, with a focus on 12 key performance areas. |
|
|
|
|
| Small Is Powerful And Sustained | Article | Nanoform | Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance. |
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|